|1.87|| +0.05 / +2.75%|
ERBA Diagnostics, Inc. develops, manufactures and markets diagnostic test kits, or assays and automated systems that are used to aid in the detection of disease markers in the areas of autoimmune and infectious diseases, clinical chemistry, hematology, and diabetes testing. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. It also designs and manufactures laboratory instruments that perform the tests and provide fast and accurate results, while reducing labor costs. It designs, manufactures, and distributes instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. It manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products. ERBA Diagnostics was founded on March 14, 2001 and is headquartered in Miami, FL.
|Mohan Gopalkrishnan||Chief Executive Officer|
|Ernesina Scala||Chief Financial Officer|
|William B. Creech||Vice President-Sales & Marketing|
|Chandra Krishnan||SVP-Global Sales, Marketing & Business Development|